Asthma News – September 12 to 17, 2018

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services Asthma Program Staff.

Study Identifies Benralizumab Responders Among COBRA Participants With Severe Asthma

A retrospective analysis of data from patients with severe asthma who participated in the COBRA trial identified key clinical characteristics that may help clinicians recognize patients who may benefit from additional targeted drug therapy, such as benralizumab.

New York State Guide for Asthma Management in Schools

The Guide was developed to help all school personnel, parents/guardians, health care providers and school boards support students with asthma. This document provides information about asthma, how to manage it at school, and how to create an asthma-friendly school building.

Health characteristics of patients with asthma, COPD and asthma–COPD overlap (ACO)

Using the NHANES database, researchers found that the ACO group represents an important subset of patients with chronic respiratory disease, with an increased burden of disease over asthma and COPD individually.

Montelukast Plus Budesonide Effective for Cough Variant Asthma

The combination of montelukast and budesonide was found more effective than budesonide alone in children with chronic cough variant asthma, in a recent retrospective study conducted in China.

Childhood Asthma Risk Assessed Using Respiratory Phenotypes

In inner city children, patterns of wheezing, lung function, and allergic sensitization identified 5 respiratory phenotypes that can help to elucidate the contributions of environmental risk factors to distinct forms of childhood asthma, according to a new study.

Asthma-Obesity Link May Cut Both Ways

Analyzing data on more than 8,600 non-obese people from 12 countries, researchers found that about 10% of those who had asthma when the study began were obese 10 years later. The same was true for only about 8% of those who didn't initially have asthma.

Body clock could be key to better asthma treatment

A study of over 300 severe asthmatics found their sputum samples were more than twice as likely to have more eosinophils in morning clinics than in the afternoon. Levels of eosinophils—a biomarker in sputum—are used to guide treatment in severe asthma patients.